Michael Petusky

Stock Analyst at Barrington Research

(2.20)
# 2,947
Out of 5,041 analysts
209
Total ratings
38.92%
Success rate
-2.51%
Average return

Stocks Rated by Michael Petusky

U.S. Physical Therapy
Oct 24, 2025
Maintains: Outperform
Price Target: $103
Current: $93.16
Upside: +10.56%
Orthofix Medical
Oct 23, 2025
Maintains: Outperform
Price Target: $17
Current: $15.97
Upside: +6.45%
Henry Schein
Oct 22, 2025
Maintains: Outperform
Price Target: $78
Current: $63.84
Upside: +22.18%
Haemonetics
Oct 21, 2025
Maintains: Outperform
Price Target: $86
Current: $51.26
Upside: +67.77%
LeMaitre Vascular
Oct 15, 2025
Maintains: Outperform
Price Target: $95
Current: $89.21
Upside: +6.49%
Merit Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $103
Current: $82.74
Upside: +24.49%
Option Care Health
Sep 23, 2025
Maintains: Outperform
Price Target: $38
Current: $27.91
Upside: +36.15%
Anika Therapeutics
Sep 23, 2025
Maintains: Outperform
Price Target: $15
Current: $10.01
Upside: +49.85%
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25$1.5
Current: $1.11
Upside: +35.14%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $27.26
Upside: -
Maintains: Outperform
Price Target: $21$18
Current: $13.11
Upside: +37.30%
Maintains: Outperform
Price Target: $2.25
Current: $1.50
Upside: +50.00%
Downgrades: Market Perform
Price Target: n/a
Current: $6.76
Upside: -